1985
DOI: 10.1126/science.3923623
|View full text |Cite
|
Sign up to set email alerts
|

Human GM-CSF: Molecular Cloning of the Complementary DNA and Purification of the Natural and Recombinant Proteins

Abstract: Clones of complementary DNA encoding the human lymphokine known as granulocyte-macrophage colony-stimulating factor (GM-CSF) were isolated by means of a mammalian cell (monkey COS cell) expression screening system. One of these clones was used to produce recombinant GM-CSF in mammalian cells. The recombinant hematopoietin was similar to the natural product that was purified to apparent homogeneity from medium conditioned by a human T-cell line. The human T-cell GM-CSF was found to be 60 percent homologous with… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

11
306
0
1

Year Published

1991
1991
2009
2009

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 1,173 publications
(319 citation statements)
references
References 44 publications
11
306
0
1
Order By: Relevance
“…BCG can be formulated in nanomicroparticle aerosol form that is effectively delivered to the lung and induces significant protective efficacy in animal models, and such an approach may further improve the protective effect on BCG:GM-CSF against pulmonary M. tuberculosis infection [34]. Continued evaluation in human trials will require the engineering of human GM-CSF into recombinant BCG strains, since cross-species receptor binding or biological activity does not exist between murine and human homologues of GM-CSF [35,36]. Nevertheless, the present study provides an excellent platform for the development of a safe and effective replacement for the current BCG vaccine to protect against tuberculosis.…”
Section: Discussionmentioning
confidence: 99%
“…BCG can be formulated in nanomicroparticle aerosol form that is effectively delivered to the lung and induces significant protective efficacy in animal models, and such an approach may further improve the protective effect on BCG:GM-CSF against pulmonary M. tuberculosis infection [34]. Continued evaluation in human trials will require the engineering of human GM-CSF into recombinant BCG strains, since cross-species receptor binding or biological activity does not exist between murine and human homologues of GM-CSF [35,36]. Nevertheless, the present study provides an excellent platform for the development of a safe and effective replacement for the current BCG vaccine to protect against tuberculosis.…”
Section: Discussionmentioning
confidence: 99%
“…Transfection of the 2.5 kb murine Gas6 cDNA, cloned into the P91023 (B) vector (Wong et al, 1985) was performed using 5 mg of plasmid using the calcium phosphate procedure. Positive clones were selected in medium containing dialyzed FCS and lacking hypoxanthine and thymidine.…”
Section: Production Of Recombinant Murine Gas6mentioning
confidence: 99%
“…The HSE element -5Ј-AGAATGTTCTAGAAG-3Ј was synthesised as a consensus sequence which confers heat shock and HSF-1 responsiveness on heterologous genes as described. 9,10 To assess promoter/enhancer strengths, plasmids were constructed using standard techniques such that different promoters and promoter/enhancer fragments were placed upstream either of the chloramphenicol acetyl transferase (CAT) gene, 7 the human GM-CSF gene 27 or the cDNA of the gibbon ape leukaemia virus fusogenic membrane glycoprotein (GALV-FMG). 2,4 Levels of gene expression were assayed using either CAT assays, 7 by measuring levels of human GM-CSF secreted from the plasmids by ELISA (Pharmingen, San Diego, CA, USA) or by semi-quantitative rtPCR as described below.…”
Section: Plasmids and Cell Linesmentioning
confidence: 99%